Taro Pharmaceutical Industries Ltd. (TARO)

Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)

42.97

0.00 (0.00%)

Inactive · Last trade price on Jun 21, 2024

TARO Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Assets

Year Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	362.91	154.5	251.13	605.18	513.35
Short-Term Investments	516.44	695.79	569.61	418.48	595.38
Cash & Cash Equivalents	879.35	850.29	820.75	1,024	1,109
Cash Growth	3.42%	3.60%	-19.82%	-7.67%	5.66%
Receivables	219.24	259.47	306.7	266.89	270.79
Inventory	204.82	226.67	210.44	180.29	153.07
Total Current Assets	1,303	1,336	1,338	1,471	1,533
Property, Plant & Equipment	217.59	190.14	199.69	205.51	209.96
Long-Term Investments	457.99	404.9	435.19	557.21	459.64
Goodwill and Intangibles	17.23	17.23	11.82	7.19	0
Other Long-Term Assets	165.85	186.82	191.78	166.13	139.05
Total Long-Term Assets	858.67	799.09	838.48	936.04	808.65
Total Assets	2,162	2,136	2,176	2,407	2,341

Liabilities

Year Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Accounts Payable	44.66	68.48	68.23	61.17	28.86
Other Current Liabilities	316.44	317.06	363.89	615.14	193.87
Total Current Liabilities	361.11	385.55	432.12	676.3	222.73
Other Long-Term Liabilities	7.96	19.11	32.8	35.12	8.76
Total Long-Term Liabilities	7.96	19.11	32.8	35.12	8.76
Total Liabilities	369.06	404.65	464.92	711.42	231.49

Shareholders' Equity

Year Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Retained Earnings	-	2,414	2,389	2,339	2,725
Comprehensive Income	0	0	-168.97	-151.62	-163.04
Shareholders' Equity	1,793	1,731	1,711	1,704	2,104

Additional Metrics

Year Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Cash (Debt)	879.35	850.29	820.75	1,024	1,109
Net Cash (Debt) Growth	3.42%	3.60%	-19.82%	-7.67%	5.66%
Net Cash Per Share	23.40	22.62	21.80	26.79	28.83
Working Capital	942.3	950.88	905.77	794.53	1,310
Book Value Per Share	47.70	46.05	45.47	44.59	54.70